Corneal Ectasia
33
3
4
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.0%
1 terminated out of 33 trials
92.3%
+5.8% vs benchmark
27%
9 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (33)
Outcomes of CTAK Surgery
KeratoConus Data Acquisition With Topography and Aberrometry
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
Corneal Topographic Changes in Different Grades of OSA
Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism
Refractive and Corneal Topographic Characteristics in Upper Egypt Children With High Cylinder
Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery
Three Different Cross-linking Protocols for Treatment of Pediatric Keratoconus
Dresden Corneal Disease and Treatment Study
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia
Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia
Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia
Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Riboflavin/Dextran or Riboflavin/Methylcellulose
Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light
Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients
Safety and Effectiveness of the PXL-Platinum 330 System